Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 16, 2005
app pub date -
Oct 18, 2004
filing date -
Mar 16, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
This invention features the use of the spirolaxine of formula (I) for the treatment of those pathologies responding to the activation of the PPAR.gamma. receptor, such as the Type 2 insulin-resistant diabetes. This invention also features a pharmaceutical composition in which the spirolaxine of formula (I) acts as active principle in association with the all-trans retinoic acid of formula (II) for the treatment of those pathologies responding to the activation of the PPAR.gamma. receptor, such as the acute malignant haemopathies.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully